Open Architecture Image-Guided Therapy Software System

开放架构影像引导治疗软件系统

• 批准号: 6935667
• 负责人: James David Stefansic
• 金额: $ 14.99万
• 依托单位: PATHFINDER THERAPEUTICS
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-04-01 至 2006-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6935667
• 关键词: bioimaging /biomedical imaging; computer program /software; computer system design /evaluation; image guided surgery /therapy

DESCRIPTION (provided by applicant): One of the important developments in disease treatment over the past decade has been the development of image-guided procedures. The rise of such systems has also been associated with a contraction of the market with a few companies becoming the dominant players in the field. In such a contracted commercial state, the field does not rapidly expand but rather has to wait for the large corporations see enough potential profit in new applications to innovate. One of the barriers to new innovation is the complexity of the imageguided procedure task, requiring understanding of three dimensional tracking systems, image to physical space registration techniques, display methodologies, graphic techniques, data IO and methods of using intraoperative data to correct preoperative assumptions or to deal with temporal changes. In this proposal we propose to create an open architecture/closed source system for image-guide procedures. Such a system would allow organizations, technology companies and other more agile innovators to prototype new systems without having to expend considerable effort outside of their expertise. It would also provide a common platform allowing consortia of organizations (academic, research and commercial) to coalesce on new applications bringing new therapeutic techniques to the market more quickly.

描述（由申请人提供）：过去十年疾病治疗的重要发展之一是图像引导手术的发展。此类系统的兴起也与市场萎缩有关，少数公司成为该领域的主导者。在这样一个契约化的商业状态下，该领域不会迅速扩张，而是必须等待大公司在新应用中看到足够的潜在利润才能进行创新。新创新的障碍之一是图像引导手术任务的复杂性，需要了解三维跟踪系统、图像到物理空间配准技术、显示方法、图形技术、数据 IO 以及使用术中数据纠正术前假设或以应对时间变化。在本提案中，我们建议为图像引导程序创建一个开放架构/闭源系统。这样的系统将允许组织、技术公司和其他更敏捷的创新者制作新系统的原型，而无需在其专业知识之外花费大量精力。它还将提供一个通用平台，允许组织联盟（学术、研究和商业）联合开发新应用，从而更快地将新的治疗技术推向市场。